|
1
|
Barman S, Pradeep SR and Srinivasan K:
Zinc supplementation alleviates the progression of diabetic
nephropathy by inhibiting the overexpression of
oxidative-stress-mediated molecular markers in
streptozotocin-induced experimental rats. J Nutr Biochem.
54:113–129. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dissanayake AM, Wheldon MC, Ahmed J and
Hood CJ: Extending metformin use in diabetic kidney disease: A
pharmacokinetic study in stage 4 diabetic nephropathy. Kidney Int
Rep. 2:705–712. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Khitan ZJ, Tzamaloukas AH, Brodsky S and
Shapiro JI: Dihydropyridine calcium channel blockers in the elderly
with diabetic nephropathy: Are they safe? J Clin Hypertens
(Greenwich). 20:203–204. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li J, Yang S, Li X, Liu D, Wang Z, Guo J,
Tan N, Gao Z, Zhao X, Zhang J, et al: Role of endoplasmic reticulum
stress in disuse osteoporosis. Bone. 97:2–14. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Montero RM, Herath A, Qureshi A,
Esfandiari E, Pusey CD, Frankel AH and Tam FWK: Defining phenotypes
in diabetic nephropathy: A novel approach using a cross-sectional
analysis of a single centre cohort. Sci Rep. 8:532018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sagoo MK and Gnudi L: Diabetic
nephropathy: Is there a role for oxidative stress? Free Radic Biol
Med. 116:50–63. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Talsma DT, Katta K, Ettema MAB, Kel B,
Kusche-Gullberg M, Daha MR, Stegeman CA, van den Born J and Wang L:
Endothelial heparan sulfate deficiency reduces inflammation and
fibrosis in murine diabetic nephropathy. Lab Invest. 98:427–438.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wei PZ, Kwan BC, Chow KM, Cheng PM, Luk
CC, Li PK and Szeto CC: Urinary mitochondrial DNA level is an
indicator of intra-renal mitochondrial depletion and renal scarring
in diabetic nephropathy. Nephrol Dial Transplant. 33:784–788. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu Z and Fan J: Islet transplantation
promotes podocyte regeneration in a model of diabetic nephropathy.
Turk J Med Sci. 47:1925–1930. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cai M, He H, Jia X, Chen S, Wang J, Shi Y,
Liu B, Xiao W and Lai S: Genome-wide microRNA profiling of bovine
milk-derived exosomes infected with Staphylococcus aureus. Cell
Stress Chaperones. 23:663–672. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kaul V, Weinberg KI, Boyd SD, Bernstein D,
Esquivel CO, Martinez OM and Krams SM: Dynamics of viral and host
immune cell microRNA expression during acute infectious
mononucleosis. Front Microbiol. 8:26662018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu L, Zhang X, Nan C, Zhao Z, Ma S, Li W,
Hu H and Liang Z: MicroRNA-182 targets protein phosphatase 1
regulatory inhibitor subunit 1C in glioblastoma. Oncotarget.
8:114677–114684. 2017.PubMed/NCBI
|
|
13
|
Tang Y, Zhang L, Tu T, Li Y, Murray D, Tu
Q and Chen JJ: MicroRNA-99a is a novel regulator of KDM6B-mediated
osteogenic differentiation of BMSCs. J Cell Mol Med. 22:2162–2176.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Y, Pang X, Wu J, Jin L, Yu Y, Gobin R
and Yu J: MicroRNA hsa-let-7b suppresses the odonto/osteogenic
differentiation capacity of stem cells from apical papilla by
targeting MMP1. J Cell Biochem. 119:6545–6554. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wen X, Han XR, Wang YJ, Wang S, Shen M,
Zhang ZF, Fan SH, Shan Q, Wang L, Li MQ, et al: MicroRNA-421
suppresses the apoptosis and autophagy of hippocampal neurons in
epilepsy mice model by inhibition of the TLR/MYD88 pathway. J Cell
Physiol. 233:7022–7034. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yan N, Wen L, Peng R, Li H, Liu H, Peng H,
Sun Y, Wu T, Chen L, Duan Q, et al: Naringenin ameliorated kidney
injury through Let-7a/TGFBR1 signaling in diabetic nephropathy. J
Diabetes Res. 2016:87387602016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang LK, Xie XN, Song XH, Su T, Chang XL,
Xu M, Liang B and Huang DY: Upregulation of miR-200b inhibits
hepatocellular carcinoma cell proliferation and migration by
targeting HMGB3 protein. Technol Cancer Res Treat.
17:15330338188064752018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yan L, Li J, Wu Q and Chen L: Specific
miRNA expression profile in the blood serum of cardiac myxoma
patients. Oncol Lett. 16:4235–4242. 2018.PubMed/NCBI
|
|
20
|
Liu H, Wang X, Liu S and Li H, Yuan X,
Feng B, Bai H, Zhao B, Chu Y and Li H: Effects and mechanism of
miR-23b on glucose-mediated epithelial-to-mesenchymal transition in
diabetic nephropathy. Int J Biochem Cell Biol. 70:149–160. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guo J, Li J, Zhao J, Yang S, Wang L, Cheng
G, Liu D, Xiao J, Liu Z and Zhao Z: MiRNA-29c regulates the
expression of inflammatory cytokines in diabetic nephropathy by
targeting tristetraprolin. Sci Rep. 7:23142017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou Z, Wan J, Hou X, Geng J, Li X and Bai
X: MicroRNA-27a promotes podocyte injury via PPARγ-mediated
β-catenin activation in diabetic nephropathy. Cell Death Dis.
8:e26582017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sun J, Li ZP, Zhang RQ and Zhang HM:
Repression of miR-217 protects against high glucose-induced
podocyte injury and insulin resistance by restoring PTEN-mediated
autophagy pathway. Biochem Biophys Res Commun. 483:318–324. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Peng R, Liu H, Peng H, Zhou J, Zha H, Chen
X, Zhang L, Sun Y, Yin P, Wen L, et al: Promoter hypermethylation
of let-7a-3 is relevant to its down-expression in diabetic
nephropathy by targeting UHRF1. Gene. 570:57–63. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu Y, Yin B, Zhang C, Zhou L and Fan J:
Hsa-let-7a functions as a tumor suppressor in renal cell carcinoma
cell lines by targeting c-myc. Biochem Biophys Res Commun.
417:371–375. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mayr C, Hemann MT and Bartel DP:
Disrupting the pairing between let-7 and Hmga2 enhances oncogenic
transformation. Science. 315:1576–1579. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu Y, Fu QZ, Pu L, Meng QG, Liu XF, Dong
SF, Yang JX and Lv GY: HMGA2 expression in renal carcinoma and its
clinical significance. J Med Biochem. 34:338–343. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu Y, Fu QZ, Pu L, Song LL, Wang YY, Liu
J, Wang ZL and Wang ZM: Effect of RNA interference of the
expression of HMGA2 on the proliferation and invasion ability of
ACHN renal cell carcinoma cells. Mol Med Rep. 16:5107–5112. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Na N, Si T, Huang Z, Miao B, Hong L, Li H
and Qiu J and Qiu J: High expression of HMGA2 predicts poor
survival in patients with clear cell renal cell carcinoma. Onco
Targets Ther. 9:7199–7205. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang M, Yao D, Wang S, Yan Q and Lu W:
Long non-coding RNA ENSMUST00000147869 protects mesangial cells
from proliferation and fibrosis induced by diabetic nephropathy.
Endocrine. 54:81–92. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lee YS and Dutta A: The tumor suppressor
microRNA let-7 represses the HMGA2 oncogene. Genes Dev.
21:1025–1030. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Huang G, Lv J, Li T, Huai G, Li X, Xiang
S, Wang L, Qin Z, Pang J, Zou B and Wang Y: Notoginsenoside R1
ameliorates podocyte injury in rats with diabetic nephropathy by
activating the PI3K/Akt signaling pathway. Int J Mol Med.
38:1179–1189. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hong JN, Li WW, Wang LL, Guo H, Jiang Y,
Gao YJ, Tu PF and Wang XM: Jiangtang decoction ameliorate diabetic
nephropathy through the regulation of PI3K/Akt-mediated NF-κB
pathways in KK-Ay mice. Chin Med. 12:132017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tan L, Wei X, Zheng L, et al: Amplified
HMGA2 promotes cell growth by regulating Akt pathway in AML. J
Cancer Res Clin Oncol. 142:389–399. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cui H, Song R, Wu J, Wang W, Chen X and
Yin J: MicroRNA-337 regulates the PI3K/AKT and Wnt/beta-catenin
signaling pathways to inhibit hepatocellular carcinoma progression
by targeting high-mobility group AT-hook 2. Am J Cancer Res.
8:405–421. 2018.PubMed/NCBI
|
